Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou GB Chemwin Technology is a specialized chemical service provider and contract research organization (CRO) based in China. The company focuses on the research, development, and production of high-quality pharmaceutical intermediates, fine chemicals, and customized building blocks for the global life sciences industry. Their core services include custom synthesis, process optimization, and the supply of specialized reagents used in drug discovery and development. By providing a vast catalog of chemical compounds and tailored synthesis solutions, GB Chemwin supports pharmaceutical and biotech companies in accelerating their R&D pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou GB Chemwin.